摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-甲基噻吩并[2,3-d]嘧啶 | 111079-29-9

中文名称
4-甲基噻吩并[2,3-d]嘧啶
中文别名
——
英文名称
4-Methylthieno[2,3-d]pyrimidine
英文别名
——
4-甲基噻吩并[2,3-d]嘧啶化学式
CAS
111079-29-9
化学式
C7H6N2S
mdl
——
分子量
150.204
InChiKey
DHQZOCRPDGMHRT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    79.5-80.5 °C
  • 沸点:
    263.6±20.0 °C(Predicted)
  • 密度:
    1.297±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2
  • 重原子数:
    10
  • 可旋转键数:
    0
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.14
  • 拓扑面积:
    54
  • 氢给体数:
    0
  • 氢受体数:
    3

SDS

SDS:17d7b6155f555e242af15b604b6e4aef
查看

反应信息

点击查看最新优质反应信息

文献信息

  • HETEROCYCLIC COMPOUNDS, PROCESS FOR PREPARATION OF THE SAME AND USE THEREOF
    申请人:SHANGHAI INSTITUTE OF MATERIA MEDICA, CHINESE ACADEMY OF SCIENCES
    公开号:US20170158680A1
    公开(公告)日:2017-06-08
    The present invention provides a heterocyclic compound represented by the formula (I), its stereoisomers, or a pharmaceutically acceptable salt thereof, pharmaceutical compositions thereof, and their use in preparing a medicament for the prevention and/or treatment of central nervous system disease.
    本发明提供了一种由公式(I)表示的杂环化合物,其立体异构体,或其药用可接受的盐,其药物组合物,以及它们用于制备预防或治疗中枢神经系统疾病的药物。
  • NOVEL COMPOUNDS
    申请人:GRAUERT Matthias
    公开号:US20130150341A1
    公开(公告)日:2013-06-13
    This invention relates to compounds of formula I their use as positive allosteric modulators of mGlu5 receptor activity, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of neurological and psychiatric disorders associated with glutamate dysfunction such as schizophrenia or cognitive decline such as dementia or cognitive impairment. A, B, X, R 1 , R 2 , R 3 have meanings given in the description.
    本发明涉及式I化合物、它们作为mGlu5受体活性的正变构调节剂的应用、含有该化合物的药物组合物,以及使用它们作为治疗和/或预防与谷氨酸功能障碍相关的神经和精神障碍的剂,如精神分裂症或认知下降,如痴呆或认知障碍。A、B、X、R1、R2、R3的含义如说明书中所述。
  • [EN] MODULATORS OF THE INTEGRATED STRESS PATHWAY<br/>[FR] MODULATEURS DE LA VOIE DE RÉPONSE INTÉGRÉE AU STRESS
    申请人:CALICO LIFE SCIENCES
    公开号:WO2017193034A1
    公开(公告)日:2017-11-09
    Provided herein are compounds, compositions, and methods useful for modulating the integrated stress response (ISR) and for treating related diseases; disorders and conditions.
    本文提供了用于调节综合应激反应(ISR)并治疗相关疾病、疾病和症状的化合物、组合物和方法。
  • PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS
    申请人:Gilead Sciences, Inc.
    公开号:US20150361068A1
    公开(公告)日:2015-12-17
    The present application provides the compounds of formula (J), or pharmaceutically acceptable salts, isomers, tautomer, or a mixture thereof, wherein n, W, A′, B′, R 1 , R 2 , and R 3 are described herein. The compounds are inhibitors to the activities of phosphatidylinositol 3-kinase (PI3K) and are useful for treating conditions mediated by one or more PI3K isoforms. The present application further provides pharmaceutical compositions that include a compound of formula (I), or pharmaceutically acceptable salts, isomers, tautomer, or mixture thereof, and methods of using these compounds and compositions for treating conditions mediated by one or more PI3K isoforms.
    本申请提供了式(J)的化合物,或其药学上可接受的盐、异构体、互变异构体或其混合物,其中n、W、A′、B′、R1、R2和R3如本文所述。这些化合物是磷脂酰肌醇3-激酶(PI3K)活性的抑制剂,可用于治疗由一个或多个PI3K同工型介导的疾病。本申请还提供了包括式(I)的化合物、或其药学上可接受的盐、异构体、互变异构体或其混合物的药物组合物,以及使用这些化合物和组合物治疗由一个或多个PI3K同工型介导的疾病的方法。
  • Agri-Horticultural Pest Control Compositions Comprising 4-(3-Butynyl)Aminopyrimidine Derivatives
    申请人:Sakai Masaaki
    公开号:US20130296271A1
    公开(公告)日:2013-11-07
    Agri-horticultural pest control compositions having outstanding control effect on pests, in particular, agri-horticultural pests, which comprise as active ingredients one or more 4-(3-butynyl)aminopyrimidine derivatives represented by the general formula [I], namely, where R 1 is typically selected from among: a) phenyl c) —SiR 5 R 6 R 7 (R 5 , R 6 , and R 7 which may be the same or different represent a linear or branched alkyl having 1-6 carbon atoms, a linear or branched haloalkyl having 1-3 carbon atoms which is substituted by one halogen atom, a linear or branched cyanoalkyl having 1-3 carbon atoms which is substituted by one cyano group, and phenyl); d) hydropgen atom; R 2 typically represents a hydrogen atom; R 3 typically represents a hydrogen atom; R 4 represents a hydrogen atom and one or more agri-horticultural pest control compounds selected from among agri-horticultural antimicrobial compounds, say, multi-site contact active compouns, nucleic acids synthesis inhibitory active compounds, mitosis and cell divesion inhibitory active compounds, and/or agri-horticultural insecticidal, miticidal or nematicidal compounds, say, acetylcholinesterase inhibitors, GABA-gated chloride antagonists, and sodium channel modulators. Since the 4-(3-butynyl)aminopyrimidine derivatives and the existing antimicrobial active compounds and/or insecticidal active compounds are used in admixture, the 4-(3-butynyl)aminopyrimidine derivatives which are useful as pest control agents, particularly as agri-horticultural pest control agents, need be used in smaller amounts and yet their antimicrobial or insecticidal activity can be improved.
    农业园艺害虫控制组合物对害虫,特别是农业园艺害虫具有杰出的控制效果,其活性成分包括一种或多种由通式[I]表示的4-(3-丁炔基)氨基嘧啶衍生物,其中R1通常从以下中选择:a)苯基;b) -SiR5R6R7(R5、R6和R7可以相同也可以不同,代表具有1-6个碳原子的直链或支链烷基,具有1-3个碳原子的直链或支链卤代烷基,被一个卤原子取代,具有1-3个碳原子的直链或支链氰基烷基,被一个氰基取代,以及苯基);d)氢原子;R2通常表示氢原子;R3通常表示氢原子;R4表示氢原子以及一种或多种从农业园艺抗微生物化合物中选择的农业园艺害虫控制化合物,比如,多位点接触活性化合物,核酸合成抑制活性化合物,有丝分裂和细胞分裂抑制活性化合物,和/或农业园艺杀虫、杀螨或杀线虫化合物,比如,乙酰胆碱酯酶抑制剂,GABA门控氯离子拮抗剂和钠通道调节剂。由于4-(3-丁炔基)氨基嘧啶衍生物和现有的抗微生物活性化合物和/或杀虫活性化合物混合使用,因此作为害虫控制剂,特别是作为农业园艺害虫控制剂有用的4-(3-丁炔基)氨基嘧啶衍生物需要以较小的量使用,但其抗微生物或杀虫活性可以得到改善。
查看更多

同类化合物

林扎戈利 替普司特 噻吩并[3,4-d]嘧啶-2,4(1H,3H,5H,7H)-二酮 噻吩并[3,2-d]嘧啶-7-甲胺 噻吩并[3,2-d]嘧啶-4-羧酸 噻吩并[3,2-d]嘧啶-4(1H)-硫酮 噻吩并[3,2-d]嘧啶,4-(甲硫基)- 噻吩并[3,2-d]嘧啶 噻吩并[3,2-D]嘧啶-7-羧酸 噻吩并[3,2-D]嘧啶-7-甲醛 噻吩并[3,2-D]嘧啶-7-基甲醇 噻吩并[3,2-D]嘧啶-2-胺 噻吩并[2,3-d]嘧啶-4-胺 噻吩并[2,3-d]嘧啶-4-硫醇 噻吩并[2,3-d]嘧啶-4(3H)-酮 噻吩并[2,3-d]嘧啶-2,4-二胺 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-甲氧苯基)-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(3-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮,3-(2-氯苯基)-1-[(2,6-二氟苯基)甲基]-6-(4-甲氧苯基)-5-甲基- 噻吩并[2,3-d]嘧啶 噻吩并[2,3-D]嘧啶-6-羧酸 噻吩并[2,3-D]嘧啶-6-甲醛 吡啶并[3’,2’:4,5]噻吩并[3,2-d]嘧啶-4(3h)-酮 乙基3-甲基-5-羰基-5H-[1]苯并噻吩并[2,3-d][1,3]噻唑并[3,2-a]嘧啶-2-羧酸酯 乙基2-(4-氯苯基)-7-甲基-9-羰基-9H-[1,3]噻唑并[3,2-a]噻吩并[3,2-d]嘧啶-6-羧酸酯 {[((4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)甲基]硫基}乙酸 [(6-甲基噻吩并[2,3-d]嘧啶-4-基)硫基]乙酸 [(4-氧代-3,4,5,6,7,8-六氢[1]苯并噻吩并[2,3-d]嘧啶-2-基)硫基]乙酸 PI3K抑制剂 PF-3758309抑制剂 Necrostatin-5; 2-[[3,4,5,6,7,8-六氢-3-(4-甲氧基苯基)-4-氧代[1]苯并噻吩并[2,3-d]嘧啶-2-基]硫代]-乙腈 N-甲基-1-噻吩并[3,2-d]嘧啶-4-基-4-哌啶甲胺 N-[2-[[3,4-二氢-4-氧代-3-[4-(2,2,2-三氟乙氧基)苯基]噻吩并[3,4-d]嘧啶-2-基]硫基]乙基]乙酰胺 N-[(1S)-2-(二甲基氨基)-1-苯基乙基]-2,6-二氢-6,6-二甲基-3-[(2-甲基噻吩并[3,2-d]嘧啶-4-基)氨基]-吡咯并[3,4-c]吡唑-5(4H)-甲酰胺盐酸盐 N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-3-(2-甲氧基苯基)-4-氧噻吩并[3,2-d]嘧啶-2-基)硫代]-乙酰胺 N-(4-氟苯基)-5,6-二甲基噻吩并[2,3-D]嘧啶-4-胺 N-(4-吗啉-4-基噻吩并[2,3-e]嘧啶-2-基)乙烷-1,2-二胺 N,N-二甲基-5,6,7,8-四氢苯并[4,5]噻吩并[2,3-D]嘧啶-4-胺 IWP2;N-(6-甲基-2-苯并噻唑基)-2-[(3,4,6,7-四氢-4-氧代-3-苯基噻吩并[3,2d]嘧啶-2-基)硫基]乙酰胺 AR-C 155858; (S)-6-[(3,5-二甲基-1H-吡唑-4-基)甲基]-5-[(4-羟基异噁唑烷-2-基)羰基]-1-异丁基-3-甲基噻吩并[2,3-d]嘧啶-2,4(1H,3H)-二酮 7-甲基噻吩并[3,2-D]嘧啶-4-胺 7-甲基-噻吩并[3,2-d]嘧啶-2,4(1h,3h)-二酮 7-甲基-噻吩并[3,2-d]嘧啶 7-甲基-5,6,7,8-四氢[1]苯并噻吩并[2,3-d]嘧啶-4(3h)-酮 7-甲基-5,6,7,8-四氢-苯并[4,5]噻吩并[2,3-d]嘧啶-4-硫醇 7-溴噻吩并[3,2-d]嘧啶 7-溴噻吩并[3,2-D]嘧啶-4(1H)-酮 7-溴-噻吩并[3,2-d]嘧啶-4-胺 7-溴-4-氯噻酚并[3,2-D]嘧啶 7-溴-2-氯噻吩并[3,2-D]嘧啶